Copyright
©The Author(s) 2019.
World J Clin Cases. Aug 26, 2019; 7(16): 2316-2321
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2316
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2316
Figure 1 Fifteen weeks after vedolizumab treatment.
- Citation: Cakir OO. Effectiveness of vedolizumab treatment in two different anti-tumor necrosis factor alpha refractory pouchitis: A case report. World J Clin Cases 2019; 7(16): 2316-2321
- URL: https://www.wjgnet.com/2307-8960/full/v7/i16/2316.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i16.2316